D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 12.73% |
| 3 | Healthcare | 11.62% |
| 4 | Financials | 8.02% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
2176
CALL
Automatic Data Processing
ADP
$109B
| $2.39M | ﹤0.01% |
14,800
| – | – |
|
|
TVRD
2177
Tvardi Therapeutics
TVRD
$20.1M
| $2.39M | ﹤0.01% |
3,631
+2,419
| +200% | +$2.01M |
|
2178
First Financial Bankshares
FFIN
$5.05B
| $2.38M | ﹤0.01% |
71,404
-23,423
| -25% | -$737K |
|
2179
Ericsson
ERIC
$32.1B
| $2.38M | ﹤0.01% |
+297,967
| New | +$2.54M |
|
|
SAFM
2180
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $2.38M | ﹤0.01% |
15,700
| – | – |
|
2181
CALL
Churchill Downs
CHDN
$6.17B
| $2.37M | ﹤0.01% |
+38,400
| New | +$2.32M |
|
2182
FirstService
FSV
$6.55B
| $2.37M | ﹤0.01% |
23,100
+10,900
| +89% | +$1.11M |
|
2183
Assembly Biosciences
ASMB
$498M
| $2.37M | ﹤0.01% |
20,056
+15,632
| +353% | +$2.36M |
|
|
MDR
2184
DELISTED
McDermott International
MDR
| $2.36M | ﹤0.01% |
1,168,707
-3,299,458
| -74% | -$20.3M |
|
2185
CALL
Takeda Pharmaceutical
TAK
$56.7B
| $2.35M | ﹤0.01% |
136,816
| – | – |
|
2186
PUT
Ternium
TX
$9.43B
| $2.35M | ﹤0.01% |
122,600
+50,900
| +71% | +$1.01M |
|
|
FSCT
2187
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $2.35M | ﹤0.01% |
61,969
-178,715
| -74% | -$6.53M |
|
2188
CALL
Truist Financial
TFC
$63.9B
| $2.35M | ﹤0.01% |
44,000
-80,000
| -65% | -$3.96M |
|
2189
PUT
Papa John's
PZZA
$1.01B
| $2.35M | ﹤0.01% |
44,800
-3,100
| -6% | -$146K |
|
2190
Arlo Technologies
ARLO
$1.58B
| $2.34M | ﹤0.01% |
686,047
+113,094
| +20% | +$411K |
|
|
ZVO
2191
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.33M | ﹤0.01% |
1,183,349
-47,508
| -4% | -$143K |
|
2192
CALL
Ionis Pharmaceuticals
IONS
$8.93B
| $2.33M | ﹤0.01% |
38,900
| – | – |
|
|
SCPE.U
2193
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
| $2.33M | ﹤0.01% |
+225,000
| New | +$2.32M |
|
2194
PUT
W.P. Carey
WPC
$16.6B
| $2.33M | ﹤0.01% |
26,546
+16,336
| +160% | +$1.39M |
|
|
LJPC
2195
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.32M | ﹤0.01% |
263,869
+112,429
| +74% | +$1.06M |
|
|
GNMK
2196
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.32M | ﹤0.01% |
382,726
+105,373
| +38% | +$658K |
|
2197
Dominion Energy
D
$62B
| $2.31M | ﹤0.01% |
28,490
-53,243
| -65% | -$4.12M |
|
2198
Enova International
ENVA
$6.09B
| $2.3M | ﹤0.01% |
111,030
-54,372
| -33% | -$1.28M |
|
2199
PUT
Fluor
FLR
$6.54B
| $2.3M | ﹤0.01% |
120,300
+82,100
| +215% | +$1.96M |
|
2200
PUT
Waste Management
WM
$95B
| $2.3M | ﹤0.01% |
20,000
+10,000
| +100% | +$1.17M |
|
Similar funds
D.E. Shaw & Co's Q3 2019 Portfolio in Review
As of Q3 2019, D.E. Shaw & Co held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- D.E. Shaw & Co added most to PayPal in Q3 2019, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- D.E. Shaw & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- D.E. Shaw & Co opened 550 new positions and closed 422 in Q3 2019.
- D.E. Shaw & Co's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.